Molecular Partners Announces upcoming poster presentations at the 2024 SITC Annual Meeting GlobeNewswire Oct 4, 2024 5:00am
Molecular Partners Announces Upcoming Top-Rated Oral Presentation on MP0712, a ²¹²Pb-labeled Radio-DARPin Therapeutic targeting DLL3 for Small Cell Lung Cancer co-developed with Orano Med, at EANM 2024 GlobeNewswire Sep 27, 2024 5:00am
Molecular Partners Reports H1 2024 Corporate Highlights and Financials GlobeNewswire Aug 26, 2024 8:00pm